Research article · 10 Dec 2025
Research articlePublished 24 Jan 2018
A qualitative, enzyme-linked immunospot assay is a promising diagnostic method for tuberculous peritonitis among continuous ambulatory peritoneal dialysis patients: A single-center experience
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The prevalence of Tuberculous Peritonitis (TBP) among Continuous Ambulatory Peritoneal Dialysis (CAPD) patients in China is unknown. A qualitative Enzyme-Linked Immunospot (ELISPOT) assay has been proven effective for Tuberculosis (TB) diagnosis. The effectiveness of ELISPOT for TBP diagnosis is unknown. We report our single-center experience of TBP management among CAPD patients. This is a single-center retrospective study of 178 CAPD patients from August 1997 to December 2015. The ELISPOT assay was used for detection of interferon (IFN)-γ, IFN-γ (PB+P8.10), and IFN-γ (P8.10) in blood and peritoneal effluent fluid in suspected cases of TBP. Antituberculous therapy combined with CAPD was administered to confirmed TBP patients. Clinical and laboratory data were reassessed. The prevalence of TBP in this study was only 0.56%, accounting for 0.9% of all peritonitis cases. The incidence of TBP was 1/806 person-months. Levels of IFN-γ, IFN-γ (PB+P8.10), and IFN-γ (P8.10) in blood and dialysate effluent were more than 10 times higher than the reference range at the onset of TBP and gradually returned to normal with antituberculous treatment. Tenckhoff catheters functioned well. The prevalence of TBP among CAPD patients was low in our center. TBP should be considered in patients with neutrophilic sterile peritonitis and no response to broad-spectrum antibacterial medication. ELISPOT is a promising diagnostic method for TBP among CAPD patients. The peritoneal catheter can be retained with early diagnosis and timely antituberculous treatment.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Biomedical Research.
Research article · 7 Oct 2025
Multimarker Approach to Assess Glycemic Control and Bone Metabolism in Type 2 Diabetes Mellitus with Potential for Enhanced Clinical Monitoring
Review article · 13 Aug 2025
Inventions in Telemedicine Shaping the Post-Pandemic Landscape: A Complete Review of Its Revolution and Influence in the USA
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomedical Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Qijun Wan”
- BylineArticles whose byline prints “Dan Zhu”
- BylineArticles whose byline prints “Ying Liao”
- BylineArticles whose byline prints “Haiying Song”
- BylineArticles whose byline prints “Jiahui Yang”
- BylineArticles whose byline prints “Xiaojuan Hou”
- BylineArticles whose byline prints “Guangkun Ma”
- BylineArticles whose byline prints “Xiujuan He”
